Spacelabs expands patient monitoring portfolio

4 December 2006

Spacelabs Healthcare, a USA-based medical equipment company listed on the London, UK Alternative Investment Market, has expanded its patient monitoring product portfolio with the launch of the MCare 300 low-acuity patient monitor.

The stand-alone monitor is fully networked within hospitals' IT infrastructure and can be customized to meet the customers' specifications for patient parameters to be monitored. Standard configuration includes three- and five-lead electrocardiogram, respiration, spot oxygen saturation, temperature and non-invasive blood pressure monitoring.

According to Space Labs, the monitor utilizes the same touch screen interface as its UltraviewSL product line and is equipped with internal default alarms that can be configured for adult, pediatric and neonatal patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight